Sign Out
Occasional gastrointestinal discomfort may occur, but these are almost invariably mild. There may be a transitory rise in serum transaminase levels in some patients. With continuation of the drug, transaminases return to pretreatment levels, even in those patients with pre-existing impairment of hepatic function.
Immune System Disorders: Frequency not known: Anaphylactic reactions including anaphylactic shock.
Skin and Subcutaneous Skin Disorders: Frequency not known: Severe skin reactions (including Stevens Johnson Syndrome, Toxic epidermal necrolysis (TEN), Erythema Multiforme (EM) and Acute Generalized Exanthematous Pustulosis (AGEP).
